COMPANY PROFILE

Portal Biotechnologies

Explore full profile

Intracellular Delivery is Critical to Many Research and Clinical Applications

Watertown, United StatesFounded 2023Biotech & Life Sciences

Valuation $50–100M Last recorded · 2026

Revenue $1–10M Latest reported FY

Headcount 100–500 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

About Portal Biotechnologies

Portal, a promising startup based in Watertown, MA, is making waves in the biotech industry with its innovative approach to cell engineering. Recently, the company secured $5 million in pre-seed funding led by Pear VC, with additional investments from Conscience VC and 10X Capital. Portal aims to revolutionize the field of cell therapy and research by developing a universal cell engineering platform. This platform is designed to enhance the biological potential of cells and make cell therapies more accessible.

Portal serves a diverse range of clients, including biotech companies, large pharmaceutical firms, academic institutions, and cell therapy manufacturers. The company operates in the global biotech market, focusing on high throughput integrations, which means they modify existing workflows to make them more efficient and effective for cell engineering.

The business model of Portal revolves around providing cutting-edge technology and expertise to its partners. They offer a beta program that has already attracted over 20 partners worldwide. This program allows early adopters to leverage Portal's technology for research and development purposes. Additionally, Portal has a referral program that rewards individuals who help connect the company with potential clients.

Portal generates revenue through partnerships and collaborations with biotech firms, pharmaceutical companies, and academic institutions. They provide their technology and expertise to these partners, helping them advance their research and development efforts. By offering a universal cell engineering platform, Portal aims to become a key player in the biotech industry, driving innovation and accessibility in cell therapy.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2023
Headquarters: Watertown, United States
Employees: 93
Open positions: 5
Dealroom signal: 94.1/100
Industry: Health
Sub-industry: Pharmaceutical, BioTechnology
Sector: Biotech & Life Sciences, Biotechnology, Genetics and genomics, Genome Engineering, Tech for Biotech and Pharma, Biotech and Pharma, Techbio, Techbio Drug Discovery
Technology: Hardware, Deep Tech
Business model: Manufacturing
Client focus: b2b
Links: Website LinkedIn

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Open roles

1 open role

Scientific PartnerCoolidge Avenue, US · 6d ago

From job postings in the last four months. Careers page ↗More startups hiring →

Funding history

3 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SEED✓Equity / VC	Jun 2026	$9M	$36M	IA Ventures · Pear Ventures · TECHU · NFX	↗
SEED✓Equity / VC	Dec 2024	$7M	$28M	IKJ Capital · Page One Ventures · Undeterred Capital · Pear Ventures	↗

Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Financials

Revenue over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

Year	Revenue	Growth
2026
2025
2024		—

Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Growth signals

Portal Biotechnologies website traffic

Latest recorded traffic for Portal Biotechnologies is 5.9K monthly website visits, up 78.8% over the last three months. Portal Biotechnologies's team grew 72.2% over the past year.

Latest monthly visits5.9K 3-month web change+78.8% 1-year team growth+72.2%

Monthly website visitsMar 2024–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Open positions

Openings linked to this company in Dealroom

Marketing Strategy and Operations ManagerSan Carlos, CA · Marketing & Communication · Aug 28, 2026 ScientistSan Carlos, CA · Data Science & Engineering · Aug 27, 2026 ScientistWatertown, MA · Data Science & Engineering · Jul 2, 2026

3 distinct openings shownExplore hiring signals →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
CTCeleris TherapeuticsPredicting biomolecular interactions and designing drugs for incurable diseases	Graz, Austria	Operational	1	$7.8M	$17M
ATArctic TherapeuticsTransforming drug discovery and development by harnessing the power of applied of genomics	Reykjavík, Iceland	Operational
ELEpigene LabsHelping cancer researchers develop new treatments and drugs by providing them with data-driven insights	Paris, France	Operational
CDC4X DiscoveryC4X Discovery - building the world's most productive drug discovery engine	Manchester, United Kingdom	Operational
TGTouchlight GeneticsDevelops a DNA production platform designed for the development of DNA vaccines for oncology and infectious diseases	London, United Kingdom	Operational
ABAtrandi BiosciencesMaking droplet microfluidics easy-to-use and accessible for cutting-edge research	Vilnius, Lithuania	Operational
BIbit.bioDeveloping a scalable technology platform capable of producing consistent batches of every human cell	Cambridge, United Kingdom	Operational
OBOctarine BioHarnessing the powers of synthetic biology to develop rare and superior cannabinoids and psychedelic derivatives	Copenhagen, Denmark	Operational